SUNWELS Co.,Ltd.

Business Details

Generates revenue from long-term care insurance, medical insurance, and disability welfare services, operating the Parkinson's Disease Specialized Home "PD House" as its core business, alongside medical-specialized housing, group homes, day services, welfare equipment business, and Kaatsu Training Business. PD House accounts for approximately 89% of net sales, and its multi-source revenue model results in a high per-resident unit price. Major customers are the National Health Insurance Associations of each prefecture.

Recent Overview

Profitability deteriorated sharply due to 13 new facility openings and recurrence-prevention measures for improper billing; the company is moving into a structural reform period

In FY2026 (ending March 2026), the company opened 13 new facilities and achieved an increase in net sales to ¥28,136 million (up 6.2% year on year); however, increased initial opening costs and a review of the operational structure accompanying recurrence-prevention measures related to improper billing issues (short-duration visits and visits without an accompanying staff member) led to an operating loss of ¥1,223 million and an ordinary loss of ¥2,168 million. A ¥1,000 million donation from the Representative Director was recorded as extraordinary income, limiting the net loss for the period to ¥1,656 million. Compounded by the effects of the FY2026 revision to medical service fees, the company plans to suspend new store openings in FY2027 (ending March 2027) and treat it as a structural reform period. Due to a breach of financial covenants (two term loans with a combined outstanding balance of ¥870 million), a material event exists regarding the going concern assumption; the company has already obtained a grace period for principal repayment from its lending banks covering April 30 to September 30, 2026 (total of ¥574 million).

Key Products

Growth Drivers

• Increasing number of Parkinson's disease patients due to progressing aging of the population and growing demand for specialized nursing care (rarity of specialization as a designated intractable disease)
• Recovery of profitability through improved occupancy rates at existing facilities (a key measure of the structural reform for FY2027, ending March 2027)
• Maintaining a high per-resident unit price through the multi-source revenue model combining long-term care insurance, medical insurance, and disability insurance
• Turning operating profit positive through a shift in the revenue model and fundamental review of the cost structure (FY2027, ending March 2027 forecast: operating income of ¥420 million)
• Boosting occupancy rates through strengthened medical partnerships to promote move-ins

Risks

• Risk of continued deterioration in profitability due to implementation of recurrence-prevention measures related to improper billing issues (short-duration visits and visits without an accompanying staff member)
• Breach of financial covenants (two term loans with commitment deadlines, combined outstanding balance of ¥870 million) and existence of a material event regarding the going concern assumption
• Adverse impact on the revenue structure from the FY2026 revision to medical service fees (a phase in which securing profitability under the current business structure is difficult)
• Cash flow risk requiring continued negotiations with lending banks for repayment grace periods (response after the end of September 2026 remains undetermined)
• Risk of prolonged initial losses due to sluggish occupancy rates at newly opened facilities
• Concerns over financial soundness due to declining equity ratio (from 22.0% to 15.2%) and high levels of interest-bearing debt (including lease obligations)
• Risk of rising operating costs and declining occupancy rates due to difficulty securing and retaining nursing care and medical personnel
• Continued recording of ¥3,207 million in fixed liabilities related to repayment of medical service fees, and risk of further future repayments